Resource

 

 

 

 

 

 

 

 

 

 

 

Fund/Investment Management

Summa Equity has invested in Pagero

04 May 2017

Summa Equity has invested in Pagero AB. Pagero AB develops and distributes cloud based communication services relating to purchase to pay, order to cash and logistic to pay processes. Summa Equity has become Pagero AB's largest shareholder through its investment. The company's management will remain shareholders and retain their positions within the company.

Summa Equity was advised by Mannheimer Swartling in the transaction.

Bird & Bird represents ARM on strategic investment in Blu Wireless Technology

04 May 2017

Bird & Bird's London corporate team advised ARM, the world's leading semiconductor IP company, on its strategic investment in Blu Wireless Technology Ltd (BWT). ARM designs microprocessors, physical intellectual property and related technology, and sells development tools to deliver the intelligence in applications ranging from sensors to servers, including smartphones, tablets, enterprise infrastructure and the internet of things. BWT is a supplier of semiconductor and system IP for mmWave and high bandwidth wireless communications markets.

Addleshaw Goddard advises Warrington B.C. on its investment in a new UK SME business bank - Redwood

04 May 2017

AG has advised Warrington Borough Council on its acquisition of a 33% stake in Redwood Financial Partners Limited, the parent company of "Redwood", marking the first investment of its type by a borough council.

Entering the market as a new UK SME Business bank, Redwood obtained its banking licence on 11 April 2017, following approval from the Financial Conduct Authority and the Prudential Regulation Authority.

Pinsent Masons advises Manchester City Council on £1bn Northern Gateway deal

02 May 2017

Pinsent Masons has advised Manchester City Council on the £1bn Northern Gateway investment deal with Far East Consortium International (FEC).
inShare47

The investment area extends north from Victoria Station and includes NOMA, the Lower Irk Valley, New Cross and Collyhurst, covering 300 acres. It has the potential to deliver around 10,000 homes over the next 10-15 years.

Walder Wyss advises Fresenius Kabi on the acquisition of Merck's biosimilars business

28 Apr 2017

Walder Wyss advises, together with Clifford Chance, Düsseldorf, Fresenius Kabi on the acquisition of Merck’s Biosimilar Business and on the intergration of the respective premises in Aubonne and Vevey. Biosimilars are a biological generic preparations of drugs and are expected to be a strongly growing pharmaceuticals market. The purchase price of up to 670 billion Euro consist of a cash compensation of 170 billion Euro payable upon closing and of product related earn out amounts of up to 500 billion Euro.